Molecular basis for the antiandrogen withdrawal syndrome |
| |
Authors: | Miyamoto Hiroshi Rahman Mujib M Chang Chawnshang |
| |
Affiliation: | George Whipple Laboratory for Cancer Research, Department of Pathology, and the Cancer Center, University of Rochester Medical Center, Rochester, New York 14642, USA. |
| |
Abstract: | In patients with prostate cancer who manifest disease progression during combined androgen blockade therapy, discontinuation of antiandrogen treatment might result in prostate-specific antigen decline, often associated with clinical improvement. The response called antiandrogen withdrawal syndrome is thus acknowledged as a general phenomenon. However, molecular mechanisms responsible for this syndrome are not completely understood. This article outlines the proposed mechanisms, including alterations of androgen receptor gene and its coregulatory proteins and activation of the signal transduction pathway, and the potential therapeutic approaches based on the specific mechanisms. |
| |
Keywords: | prostate cancer combined androgen blockade androgen receptor androgen receptor coregulator prostate‐specific antigen |
本文献已被 PubMed 等数据库收录! |
|